These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32653550)

  • 1. Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?
    Bendjelid K; Giraud R; Von Düring S
    Anaesth Crit Care Pain Med; 2020 Aug; 39(4):451-452. PubMed ID: 32653550
    [No Abstract]   [Full Text] [Related]  

  • 2. Almitrine as a non-ventilatory strategy to improve intrapulmonary shunt in COVID-19 patients.
    Losser MR; Lapoix C; Delannoy M; Champigneulle B; Payen D
    Anaesth Crit Care Pain Med; 2020 Aug; 39(4):467-469. PubMed ID: 32505756
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of almitrine bismesylate and inhaled nitric oxide on oxygenation in COVID-19 acute respiratory distress syndrome.
    Cardinale M; Esnault P; Cotte J; Cungi PJ; Goutorbe P
    Anaesth Crit Care Pain Med; 2020 Aug; 39(4):471-472. PubMed ID: 32505755
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of Almitrine in the Treatment of Hypoxemia in Sars-Cov-2 Acute Respiratory Distress Syndrome.
    Barthélémy R; Blot PL; Tiepolo A; Le Gall A; Mayeur C; Gaugain S; Morisson L; Gayat E; Mebazaa A; Chousterman BG
    Chest; 2020 Nov; 158(5):2003-2006. PubMed ID: 32512007
    [No Abstract]   [Full Text] [Related]  

  • 5. Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?
    Caocci G; La Nasa G
    Ann Hematol; 2020 Jul; 99(7):1675-1676. PubMed ID: 32405693
    [No Abstract]   [Full Text] [Related]  

  • 6. Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS).
    Altschuler EL; Kast RE
    Med Hypotheses; 2020 Aug; 141():109774. PubMed ID: 32344275
    [No Abstract]   [Full Text] [Related]  

  • 7. P-selectin blockade in COVID-19-related ARDS.
    Neri T; Nieri D; Celi A
    Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1237-L1238. PubMed ID: 32464083
    [No Abstract]   [Full Text] [Related]  

  • 8. Case 18-2020: A 73-Year-Old Man with Hypoxemic Respiratory Failure and Cardiac Dysfunction.
    Kazi DS; Martin LM; Litmanovich D; Pinto DS; Clerkin KJ; Zimetbaum PJ; Dudzinski DM
    N Engl J Med; 2020 Jun; 382(24):2354-2364. PubMed ID: 32521138
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombolysis restores perfusion in COVID-19 hypoxia.
    Arachchillage DJ; Stacey A; Akor F; Scotz M; Laffan M
    Br J Haematol; 2020 Sep; 190(5):e270-e274. PubMed ID: 32735730
    [No Abstract]   [Full Text] [Related]  

  • 10. Treating hypoxemic patients with SARS-COV-2 pneumonia: Back to applied physiology.
    Bendjelid K; Raphaël G
    Anaesth Crit Care Pain Med; 2020 Jun; 39(3):389-390. PubMed ID: 32305591
    [No Abstract]   [Full Text] [Related]  

  • 11. Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166.
    Quesada-Gomez JM; Entrenas-Castillo M; Bouillon R
    J Steroid Biochem Mol Biol; 2020 Sep; 202():105719. PubMed ID: 32535032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?
    Cadegiani FA
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E587-E588. PubMed ID: 32297520
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia.
    Zhou W; Liu Y; Tian D; Wang C; Wang S; Cheng J; Hu M; Fang M; Gao Y
    Signal Transduct Target Ther; 2020 Feb; 5(1):18. PubMed ID: 32296012
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticoagulants and immunosuppressants in COVID-19: Bullets to Defeat MicroCLOTS.
    Turi S; Nardelli P; Landoni G
    Ann Card Anaesth; 2020; 23(3):258-259. PubMed ID: 32687078
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrinolytic therapy in patients with COVID-19 and acute respiratory distress syndrome: Is this a feasible approach?
    Savioli F; Rocha L; Góis A; Nakano LC
    J Trauma Acute Care Surg; 2020 Dec; 89(6):e187-e188. PubMed ID: 32868539
    [No Abstract]   [Full Text] [Related]  

  • 16. Almitrine Infusion in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Acute Respiratory Distress Syndrome: A Single-Center Observational Study.
    Caplan M; Goutay J; Bignon A; Jaillette E; Favory R; Mathieu D; Parmentier-Decrucq E; Poissy J; Duburcq T;
    Crit Care Med; 2021 Feb; 49(2):e191-e198. PubMed ID: 33093279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19-related Acute Respiratory Distress Syndrome: Not So Atypical.
    Bos LDJ
    Am J Respir Crit Care Med; 2020 Aug; 202(4):622-624. PubMed ID: 32579026
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk of COVID-19 disease in the elderly population and physiotherapy.
    Özkeskin M; Elibol N; Bakırhan S
    Physiotherapy; 2020 Sep; 108():76-77. PubMed ID: 32717618
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of almitrine as a rescue therapy for refractory hypoxemia in COVID and non-COVID acute respiratory distress syndrome. A retrospective monocenter study.
    Blot PL; DE Roquetaillade C; Deniau B; Gaugain S; Kindermans M; Julian N; LE Dorze M; Mebazaa A; Chousterman BG; Barthélémy R
    Minerva Anestesiol; 2023 Mar; 89(3):157-165. PubMed ID: 36287391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reinventing the Wheel in ARDS: Awake Proning in COVID-19.
    Sryma PB; Mittal S; Madan K; Mohan A; Hadda V; Tiwari P; Guleria R
    Arch Bronconeumol (Engl Ed); 2020 Nov; 56(11):747-749. PubMed ID: 32736877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.